Below is a table with a list of the market segments demonstrating greater than 10% compound annual growth rate for the associated region through 2022, drawn from our reports on tissue engineering & cell therapy, wound management, ablation technologies, stroke, peripheral stents, and sealants/glues/hemostats. Products with over 10% CAGR in sales are shown in descending order of CAGR.
| Rank | Product | Topic | Region |
|---|---|---|---|
| 1 | General, gastrointestinal, ob/gyn, other | tissue/cell | WW |
| 2 | Ophthalmology | tissue/cell | WW |
| 3 | Organ Replacement/ Repair | tissue/cell | WW |
| 4 | Urological | tissue/cell | WW |
| 5 | Neurological | tissue/cell | WW |
| 6 | Autoimmune Diseases | tissue/cell | WW |
| 7 | CV/ Vascular | tissue/cell | WW |
| 8 | Bioengineered skin and skin substitutes | wound | Rest of A/P |
| 9 | Peripheral drug-eluting stents (A/P) | peripheral interventional | A/P |
| 10 | Peripheral drug eluting stents | peripheral interventional | RoW |
| 11 | Peripheral drug-eluting stents (US) | peripheral interventional | US |
| 12 | Negative pressure wound therapy | wound | Germany |
| 13 | Hydrocolloid dressings | wound | Rest of A/P |
| 14 | Cancer | tissue/cell | WW |
| 15 | Foam dressings | wound | Rest of A/P |
| 16 | Growth factors | wound | Rest of A/P |
| 17 | Alginate dressings | wound | Rest of A/P |
| 18 | Dental | tissue/cell | WW |
| 19 | Bioengineered skin and skin substitutes | wound | Japan |
| 20 | Hemostats | sealants, glues, hemostats | A/P |
| 21 | Skin/ Integumentary | tissue/cell | WW |
| 22 | Bioengineered skin and skin substitutes | sealants, glues, hemostats | US |
| 23 | Bioengineered skin and skin substitutes | sealants, glues, hemostats | WW |
| 24 | Film dressings | wound | Rest of A/P |
| 25 | Surgical sealants | sealants, glues, hemostats | A/P |
| 26 | Hydrogel dressings | wound | Rest of A/P |
| 27 | TAA Stent grafts | peripheral interventional | A/P |
| 28 | Negative pressure wound therapy | wound | RoW |
| 29 | Biological glues | sealants, glues, hemostats | A/P |
| 30 | Foam | wound | RoW |
| 31 | Hydrocolloid | wound | Germany |
| 32 | AAA Stent grafts | peripheral interventional | A/P |
| 33 | Cerebral thrombectomy systems | stroke | A/P |
| 34 | High-strength medical glues | sealants, glues, hemostats | A/P |
| 35 | Carotid artery stenting systems | stroke | A/P |
| 36 | Cardiac RF ablation products | ablation | A/P |
| 37 | Alginate dressings | wound | Germany |
| 38 | Peripheral venous stents | peripheral interventional | A/P |
| 39 | Cerebral thrombectomy systems | stroke | US |
| 40 | Left atrial appendage closure systems | stroke | A/P |
| 41 | Cyanoacrylate glues | sealants, glues, hemostats | A/P |
| 42 | Foam dressings | wound | Rest of EU |
| 43 | Foam dressings | wound | Korea |
| 44 | Cryoablation cardiac & vascular products | ablation | A/P |
| 45 | Bioengineered skin and skin substitutes | wound | Germany |
| 46 | Thrombin, collagen & gelatin-based sealants | sealants, glues, hemostats | A/P |
| 47 | Cardiac RF ablation products | ablation | RoW |
| 48 | Bioengineered skin and skin substitutes | wound | RoW |
| 49 | Microwave oncologic ablation products | ablation | A/P |
Note source links: Tissue/Cell, Wound, Sealants/Glues/Hemostats, Peripheral Stents, Stroke, Ablation.
Source: MedMarket Diligence Reports
